Drug Profile
CP 154526
Alternative Names: antalarminLatest Information Update: 20 Jun 2002
Price :
$50
*
At a glance
- Originator Pfizer
- Developer Eisai Co Ltd; Pfizer
- Class Antidepressants
- Mechanism of Action Corticotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder